Prev: Advisory Panel Guidance on Minimum Retesting Intervals for Lab TestsNext: Review for the generalist: The antinuclear antibody test in children - When to use it and what to do with a positive titer
Record 054 · Research · 2024
Identifying antinuclear antibody positive individuals at risk for developing systemic autoimmune disease: development and validation of a real-time risk model
Frontiers in Immunology · requested inclusion
“Development and validation of an electronic health record risk model for systemic autoimmune disease among people with positive ANA.”
Development and validation of an electronic health record risk model for systemic autoimmune disease among people with positive ANA. Limits noted in the record: Risk estimates from this selected clinical population are not a diagnosis or a general-population probability. A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- risk-prediction
- positive-ana
- titer
Research
Also in this file
View all in file
Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-201515.43.E · Frontiers in Immunology
Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?22.34.E · Archives of Rheumatology
Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease23.35.E · BMC Rheumatology
High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease08.36.E · Lupus